Low-dose Initiation of Buprenorphine/naloxone for the Management of Chronic Non-cancer Pain in Patients on Long-term Opioid Therapy: A Case Series.
Maya RattanavongDonica KwanDerek J JorgensonEric LandryRadhika MarwahKatelyn C HalpapePublished in: Canadian journal of pain = Revue canadienne de la douleur (2024)
Low-dose initiation is an effective approach to transition patients with chronic non-cancer pain from long-term opioid therapy to buprenorphine/naloxone without major complications or worsening pain.
Keyphrases
- chronic pain
- pain management
- low dose
- papillary thyroid
- neuropathic pain
- end stage renal disease
- high dose
- squamous cell
- ejection fraction
- newly diagnosed
- squamous cell carcinoma
- prognostic factors
- stem cells
- peritoneal dialysis
- spinal cord injury
- mesenchymal stem cells
- bone marrow
- young adults
- smoking cessation
- childhood cancer